A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A southwest oncology group trial
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin
1985 • 392 citations
Cancer Statistics, 1989
1989 • 315 citations
Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
1984 • 262 citations
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
1987 • 79 citations
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
1988 • 75 citations
Chemotherapy of cervical carcinoma.
1982 • 65 citations
Modulation of 5-fluorouracil toxicity by allopurinol in man
1981 • 53 citations
Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study.
1986 • 42 citations
A phase II study of cis‐diamminedichloroplatinum and 5‐fluorouracil in advanced upper aerodigestive neoplasms
1984 • 27 citations
Allopurinol modulation of fluorouracil toxicity
1981 • 21 citations
Phosphoriboxyl transferase in colon tumor and normal mucosa as an aid in adjuvant chemotherapy with 5-fluorouracil (NSC-19893).
1974 • 16 citations
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule.
1982 • 11 citations
Phase I-II trial of high dose 5-FU infusion with allopurinol in metastatic colorectal cancer
1982 • 2 citations
Failure of Allopurinol to Provide Clinically Significant Protection against the Hematologic Toxicity of a Bolus 5-FU Schedule
1986 • 2 citations
Cited By (0)
No citing papers found in database